Provided by Tiger Trade Technology Pte. Ltd.

Maravai LifeSciences Holdings, Inc.

3.07
+0.09003.02%
Post-market: 3.070.00000.00%18:45 EDT
Volume:3.48M
Turnover:10.65M
Market Cap:789.20M
PE:-3.39
High:3.13
Open:3.07
Low:2.98
Close:2.98
52wk High:4.11
52wk Low:1.67
Shares:257.07M
Float Shares:202.67M
Volume Ratio:1.43
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9059
EPS(LYR):-0.9059
ROE:-48.59%
ROA:-8.83%
PB:3.72
PE(LYR):-3.39

Loading ...

Feb 20, 2025

Correspondence

Form CORRESP - Correspondence
Jan 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 17, 2024

Correspondence

Form CORRESP - Correspondence
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 29, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Correspondence

Form CORRESP - Correspondence
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 10, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities